Structural and functional insights on the roles of molecular chaperones in the mistargeting and aggregation phenotypes associated with primary hyperoxaluria type I

被引:11
作者
Angel Fernandez-Higuero, Jose [1 ,2 ]
Betancor-Fernandez, Isabel [3 ]
Mesa-Torres, Noel [4 ]
Muga, Arturo [1 ,2 ]
Salido, Eduardo [3 ]
Pey, Angel L. [4 ]
机构
[1] Univ Basque Country UPV EHU, Fac Sci & Technol, Biofisika Inst, UPV EHU,CSIC, Bilbao, Spain
[2] Univ Basque Country UPV EHU, Fac Sci & Technol, Dept Biochem & Mol Biol, Bilbao, Spain
[3] Univ La Laguna, ITB, Hosp Univ Canarias, Ctr Biomed Res Rare Dis CIBERER, Tenerife, Spain
[4] Univ Granada, Dept Phys Chem, Granada, Spain
来源
MOLECULAR CHAPERONES IN HUMAN DISORDERS | 2019年 / 114卷
关键词
ALANINE-GLYOXYLATE AMINOTRANSFERASE; NUCLEOTIDE EXCHANGE FACTORS; SHOCK-PROTEIN; 90; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MISSENSE MUTATIONS; OPEN CONFORMATION; CHARGED LINKER; AGXT MUTATION; HSP90;
D O I
10.1016/bs.apcsb.2018.09.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To carry out their biological function in cells, proteins must be folded and targeted to the appropriate subcellular location. These processes are controlled by a vast collection of interacting proteins collectively known as the protein homeostasis network, in which molecular chaperones play a prominent role. Protein homeostasis can be impaired by inherited mutations leading to genetic diseases. In this chapter, we focus on a particular disease, primary hyperoxaluria type 1 (PH1), in which disease-associated mutations exacerbate protein aggregation in the cell and mistarget the peroxisomal alanine: glyoxylate aminotransferase (AGT) protein to mitochondria, in part due to native state destabilization and enhanced interaction with Hsp60, 70 and 90 chaperone systems. After a general introduction of molecular chaperones and PH1, we review our current knowledge on the structural and energetic features of PH1-causing mutants that lead to these particular pathogenic mechanisms. From this perspective, and in the context of the key role of molecular chaperones in PH1 pathogenesis, we present and discuss current and future perspectives for pharmacological treatments for this disease.
引用
收藏
页码:119 / 152
页数:34
相关论文
共 141 条
[41]   A Proteome-Wide Perspective on Peroxisome Targeting Signal 1(PTS1)-Pex5p Affinities [J].
Ghosh, Debdip ;
Berg, Jeremy M. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2010, 132 (11) :3973-3979
[42]  
Gray John, 2016, Commun Integr Biol, V9, pe1119343, DOI 10.1080/19420889.2015.1119343
[43]   Protein misfolding and human disease [J].
Gregersen, Niels ;
Bross, Peter ;
Vang, Soren ;
Christensen, Jane H. .
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, 2006, 7 :103-124
[44]   A DNAJB Chaperone Subfamily with HDAC-Dependent Activities Suppresses Toxic Protein Aggregation [J].
Hageman, Jurre ;
Rujano, Maria A. ;
van Waarde, Maria A. W. H. ;
Kakkar, Vaishali ;
Dirks, Ron P. ;
Govorukhina, Natalia ;
Oosterveld-Hut, Henderika M. J. ;
Lubsen, Nicolette H. ;
Kampinga, Harm H. .
MOLECULAR CELL, 2010, 37 (03) :355-369
[45]   Molecular chaperones in protein folding and proteostasis [J].
Hartl, F. Ulrich ;
Bracher, Andreas ;
Hayer-Hartl, Manajit .
NATURE, 2011, 475 (7356) :324-332
[46]   Converging concepts of protein folding in vitro and in vivo [J].
Hartl, F. Ulrich ;
Hayer-Hartl, Manajit .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2009, 16 (06) :574-581
[47]   Protein folding - Molecular chaperones in the cytosol: from nascent chain to folded protein [J].
Hartl, FU ;
Hayer-Hartl, M .
SCIENCE, 2002, 295 (5561) :1852-1858
[48]   The GroEL-GroES Chaperonin Machine: A Nano-Cage for Protein Folding [J].
Hayer-Hartl, Manajit ;
Bracher, Andreas ;
Hartl, F. Ulrich .
TRENDS IN BIOCHEMICAL SCIENCES, 2016, 41 (01) :62-76
[49]  
Hellenkamp B, 2017, NAT METHODS, V14, P174, DOI [10.1038/nmeth.4081, 10.1038/NMETH.4081]
[50]   The cytosolic DnaJ-like protein Djp1p is involved specifically in peroxisomal protein import [J].
Hettema, EH ;
Ruigrok, CCM ;
Koerkamp, MG ;
van den Berg, M ;
Tabak, HF ;
Distel, B ;
Braakman, I .
JOURNAL OF CELL BIOLOGY, 1998, 142 (02) :421-434